Neoadjuvant mFOLFOXIRI chemotherapy-improved survival benefit comparing with CRT in locally advanced rectal cancer: A propensity score matched analysis from two prospective trials

Zhang, JW; Li, JX; Xie, XY; Cai, Y; Hu, HB; Wu, ZH; Ling, JY; Deng, YH

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):

打开APP